Medicus Pharma Ltd. (MDCX)

Medicus Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	14.94	7.65	4.27	0.33	0.26
Research & Development	6.5	3.53	0.19	0.65	1.18
Operating Expenses	21.44	11.18	4.46	0.98	1.44
Operating Income	-21.44	-11.18	-4.46	-0.98	-1.44
Interest Expense	-0.06	-0.08	-1.25	-1.1	-0.69
Interest & Investment Income	0.18	0.1	-	-	-
Other Non Operating Income (Expenses)	-4.95	-	0.67	0.39	0.08
EBT Excluding Unusual Items	-26.27	-11.16	-5.04	-1.69	-2.06
Other Unusual Items	-0.77	-	-0.27	-	-
Pretax Income	-35.75	-11.16	-5.31	-1.69	-2.06
Net Income	-35.75	-11.16	-5.31	-1.69	-2.06
Net Income to Common	-35.75	-11.16	-5.31	-1.69	-2.06
Shares Outstanding (Basic)	15	10	3	2	3
Shares Outstanding (Diluted)	15	10	3	2	3
Shares Change (YoY)	75.66%	176.45%	84.60%	-41.41%	-
EPS (Basic)	-2.31	-1.16	-1.53	-0.90	-0.64
EPS (Diluted)	-2.31	-1.16	-1.53	-0.90	-0.64
EBITDA	-	-11.08	-	-	-
D&A For EBITDA	-	0.1	-	-	-
EBIT	-21.44	-11.18	-4.46	-0.98	-1.44

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q